CTOs on the Move

Cellenkos Incorporated

www.cellenkosinc.com

 
Cellenkos is an early stage clinical biotechnology company that focuses on cord blood-derived T-regulatory cellular therapies for the treatment of autoimmune diseases and inflammatory conditions. Cellenkos is founded on the technologies arising from the laboratory investigations of Simrit Parmar, M.D. Cellenkos` lead product CK0801 delivers clinically meaningful doses of allogeneic cord blood T-regulatory cells to overcome immune dysfunction.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details
Elizabeth Read
 Chief Technology Officer Profile

Funding

Cellenkos Incorporated raised $15M on 11/04/2021

Similar Companies

Health IQ

At Health IQ, we believe the best way to improve the health of the world is to celebrate the health conscious rather than harassing those who are not.

PDI, Inc.

PDI Inc. is a provider of contract sales teams to pharmaceutical companies, offering a range of sales support services.

Dfh

Dfh is a Hiawatha, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

vante

vante is a Tucson, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

St. Joseph Health System

St. Joseph Health System is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tawas City, MI. To find more information about St. Joseph Health System, please visit www.sjhsys.org